As a new-type foreign trade service provider driven by both technological transformation and foreign trade business, HiSiaddi has established a "1+2+3+4=1" service system and can supply bronopol sourced from multiple well-known original manufacturers. With over ten years of market experience and technological transformation cooperation with factories, HiSiaddi possesses rich experience in addressing product compliance issues. The following is a case of compliance handling for bronopol delivered by HiSiaddi.
Should you require further consultation on bronopol product compliance issues, please contact HiSiaddi customer service.
Headquartered in Paris, France, Sofibel specializes in salon medical repair ointments, organic infant care products and dermatological prescription skincare products. All its product categories are filed with France’s ANSM drug regulatory authority, included in the EU EC1223 cosmetic regulation catalog and REACH chemical control list. It supplies French chain pharmacies and high-end European beauty collection supermarkets. All raw material documents must be archived in EU cosmetic safety assessment dossiers; non-compliant raw materials will bar finished products from market sales. Its annual bronopol demand totals 75 tons (32 tons infant & child care grade, 28 tons medical dressing grade, 15 tons salon essence grade). It previously purchased bronopol imported from the UK year-round. Faced with surging European raw material prices and tight supply, it selected a domestic refined bronopol factory for trial procurement of 15 tons. After stock preparation, three major compliance issues emerged blocking EU market access, domestic hazardous goods export customs declaration and French drug regulatory raw material filing, leaving goods stranded at ports unable to be shipped. The domestic manufacturer could only provide basic factory COA without capabilities for EU compliance implementation and limited understanding of hazardous goods export customs declaration rules, making it unable to resolve compliance barriers. The client urgently entrusted HiSiaddi’s foreign trade team to fully coordinate full-chain compliance rectification.
The domestic bronopol manufacturer had not completed formal EU REACH registration and could only provide simple SGS test reports. EU regulations mandate full REACH substance registration and designation of an EU local sole representative for annual imports exceeding 1 ton of bronopol, with raw material information required to be logged into the CosIng cosmetic raw material database. Existing documents failed to meet French customs entry inspection standards, leading to direct detention and return of goods upon arrival at Le Havre Port. Meanwhile, client drug regulatory filings required GLP laboratory toxicology dossiers, which the manufacturer could not provide.
Bronopol (CAS: 52-51-7, UN3241, Class 4.1 flammable hazardous goods, HS Code 2905590040 under HiSiaddi classification) requires five supporting documents for customs declaration under new domestic hazardous goods export regulations: hazardous goods classification identification report, packaging performance certificate, bilingual compliant SDS, hazardous goods labeling and manufacturer declaration of conformity. The manufacturer only provided simple Chinese MSDS; packaging lacked hazardous goods packaging certificates, and labels carried no French-English bilingual hazard identifiers, failing domestic outbound commodity inspection and customs declaration procedures of the Ministry of Commerce of the People’s Republic of China.
The manufacturer’s COA only listed main content data, missing four mandatory EU-controlled test items: free formaldehyde, heavy metals, bromide ions and nitrosamine derivatives. French drug regulatory authorities require raw material filing dossiers to include full-item test reports issued by CNAS and EU dual-accredited laboratories. Existing reports cannot be used for the client’s finished product filings, rendering raw materials unprocessable even after port arrival.
Most domestic bronopol manufacturers prioritize production over export compliance, manufacturing in accordance with national standards without familiarity with EU cosmetic access regulations and domestic hazardous goods customs declaration rules, making them unable to assist clients in supplementing compliance documents. The client once planned full-container return shipments to switch back to original UK imported materials.
1. HiSiaddi cooperated with EU local compliance institutions to appoint a German compliance enterprise as the REACH sole representative for this bronopol model. Leveraging existing joint registration dossiers of the substance, it completed annual tonnage notification of 75 tons under REACH, simultaneously logging raw material information into the EU CosIng raw material catalog and obtaining official filing receipts.
2. Coordinate domestic GLP-qualified third-party laboratories to conduct full-item testing of bronopol toxicology, physical and chemical properties and impurities in accordance with EU SCCS standards, issuing Chinese-French-English trilingual safety assessment reports. All documents are archived into the client’s French ANSM drug regulatory dossiers to meet cosmetic raw material filing requirements.
1. Submit samples to customs-accredited laboratories to issue hazard characteristic classification identification reports confirming UN3241, Class 4.1, Packaging Group III.
2. Coordinate the factory to replace packaging with compliant hazardous goods packaging: aluminum foil inner bags plus thickened fiber hazardous goods drums, and submit packaging samples to testing institutions for issuance of "Outbound Goods Packaging Performance Inspection Certificate" and "Hazardous Goods Packaging Use Identification Certificate".
3. Recompile 16-item Chinese-English bilingual SDS, produce French-English-Chinese trilingual hazardous goods labels in accordance with GHS specifications, and supplement factory-stamped "Declaration of Conformity for Hazardous Chemical Products" to complete all statutory documents required for customs declaration and smoothly pass outbound commodity inspection.
HiSiaddi arranged CNAS-accredited third-party testing institutions to conduct batch-by-batch testing of five core indicators of bronopol in accordance with EU cosmetic limit standards: main content, inorganic bromide, free formaldehyde, heavy metals and nitrosamines, issuing bilingual COA analysis certificates. Original test reports accompany each batch of goods to meet incoming quality inspection and drug regulatory archiving requirements of French pharmaceutical factories.
1. After rectification, the first batch of 15 tons of goods successfully completed domestic customs declaration and French port clearance, warehoused at the client’s production factory in Paris. Raw material testing confirmed full compliance with ANSM control standards, enabling smooth launch of mass production on three production lines.
2. Finished products manufactured with domestic bronopol passed French cosmetic market launch sampling inspection and successfully entered offline French chain pharmacies.
3. Comprehensive procurement costs decreased by 31.2% compared with UK imported raw materials, and lead times were shortened from 90 days to 32 days. Sofibel formally terminated annual procurement contracts with UK suppliers and signed a quarterly delivery annual supply agreement of 75 tons with HiSiaddi. HiSiaddi undertakes full-process control of compliance documents for each batch of products and advance pre-review of customs declaration and EU market access documents.
Domestic manufacturers can only provide basic factory delivery documents, while mid-to-high-end European and American cosmetic clients are subject to dual regulatory constraints of local drug authorities and customs. Missing any compliance document will lead to detention and scrapping of full batches of goods. Low-end industrial procurement for water treatment and low-cost daily chemicals faces loose compliance requirements without rigorous drug regulatory inspection.
European mid-to-high-end cosmetic enterprises prioritize full-process pre-control of export customs declaration compliance, importing country market access and drug regulatory filing documents when purchasing raw materials, beyond focusing on quality and unit prices, to avoid massive losses caused by detained goods and unmarketable finished products.
Moving beyond the simple commodity resale model, HiSiaddi connects four compliance segments: domestic hazardous goods commodity inspection, third-party testing, EU regulatory registration and overseas drug regulatory filing, making up for manufacturers’ compliance shortcomings and locking in high-quality European mid-to-high-end clients through one-stop compliance capabilities.
Should you require further consultation on bronopol product compliance issues, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
